Diagnostic Performance and Usability of the Genedrive<sup>®</sup> HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia

Diagnostic Performance and Usability of the Genedrive<sup>®</sup> HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia

Point-of-care diagnostics have the potential to increase diagnosis and linkage to care and help reach the WHO targets to eliminate hepatitis C virus (HCV) by 2030. Here, we evaluated the diagnostic accuracy of Genedrive HCV ID assay for the qualitative detection of HCV RNA in decentralized settings...

Full description

Bibliographic Details
Main Authors: Francois M. J. Lamoury, Richard Njouom, Marie Amougou-Atsama, Euloge Yiagnigni Mfopou, Nino Berishvili, Manana Sologashvili, Emmanuel Fajardo, Agnes Malobela, Aurélien Macé, Maxwell Chirehwa, Maia Alkhazashvili, Elena Ivanova Reipold
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Diagnostics
Subjects:
Hepatitis C
HCV RNA
diagnostics
point-of-care
Genedrive
Online Access:https://www.mdpi.com/2075-4418/11/5/746

Internet

https://www.mdpi.com/2075-4418/11/5/746

Similar Items